Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 9, 2026

Singapore Cold Chain Logistics Market Set to Surpass Valuation of US$ 3,942.30 Million By 2035 | Astute Analytica

View original at globenewswire.com
“SATS Ltd’s Food Solutions division saw revenue grow by $33.8 million in the final quarter of FY2025, largely driven by the recovery of chilled meal catering for aviation and institutional clients.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Authorities recorded a foodborne illness rate of 22.8 cases per 100,000 population in 2024

    80% confidence

  • Vegetable farm productivity hit 231.4 tons per hectare in 2025

    80% confidence

  • The regulated electricity tariff for Jan-Mar 2026 is set at 26.71 cents per kWh

    80% confidence

  • Smart refrigeration systems in the Singapore cold chain logistics market are now delivering energy savings of up to 30%

    80% confidence

  • The Singapore cold chain logistics market is valued at approximately USD 2,010 million, with a projected trajectory to breach USD 3,942.30 million by 2035, growing at a CAGR of 7.40% during the forecast period 2026–2035

    80% confidence

  • The nation now sources food from 187 countries, a diversification that requires sophisticated chilled supply chains

    80% confidence

  • Integrated IT platforms in new facilities reduce customer lead times by 40%

    80% confidence

  • Red Lion 2's automation is projected to increase warehouse productivity by 100% compared to manual processes

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Singapore Cold Chain Logistics Market Set to Surpass Valuation of US$ 3,942.30 Million By 2035 | Astute Analytica — Source | Via News | ViaNews Market